Literature DB >> 34215372

Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus.

Chris Wincup1, Anna Radziszewska2.   

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disorder characterized by abnormalities within the innate and adaptive immune systems. Activation and proliferation of a wide array of immune cells require significant up-regulation in cellular energy metabolism, with the mitochondria playing an essential role in the initiation and maintenance of this response. This article highlights how abnormal mitochondrial function may occur in SLE and focuses on how energy metabolism, oxidative stress, and impaired mitochondrial repair play a role in the pathogenesis of the disease. How this may represent an appealing novel therapeutic target for future drug therapy in SLE also is discussed.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antimitochondrial antibodies; Autoimmunity; Immunometabolism; Mitochondria; Mitophagy; Reactive oxygen species; Systemic lupus erythematosus; T-cells

Mesh:

Year:  2021        PMID: 34215372     DOI: 10.1016/j.rdc.2021.05.001

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN: 0889-857X            Impact factor:   2.670


  3 in total

Review 1.  The role of mitochondria in rheumatic diseases.

Authors:  Yann L C Becker; Bhargavi Duvvuri; Paul R Fortin; Christian Lood; Eric Boilard
Journal:  Nat Rev Rheumatol       Date:  2022-09-29       Impact factor: 32.286

Review 2.  Mitochondrial impairment and repair in the pathogenesis of systemic lupus erythematosus.

Authors:  Like Zhao; Xianda Hu; Fei Xiao; Xuan Zhang; Lidan Zhao; Min Wang
Journal:  Front Immunol       Date:  2022-07-25       Impact factor: 8.786

Review 3.  Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases.

Authors:  Paweł Kowalczyk; Dorota Sulejczak; Patrycja Kleczkowska; Iwona Bukowska-Ośko; Marzena Kucia; Marta Popiel; Ewa Wietrak; Karol Kramkowski; Karol Wrzosek; Katarzyna Kaczyńska
Journal:  Int J Mol Sci       Date:  2021-12-13       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.